Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
Thomas Boyer(Centre Hospitalier Universitaire Amiens-Picardie), Howard Monsour(Center for Digestive and Liver Diseases), Marco Olivera‐Martinez, Fredric Regenstein, John R. Lake(University of Minnesota), Madhavi Rudraraju, Adnan Said(University of Wisconsin–Madison), Paul Y. Kwo(Palo Alto University), Kirti Shetty, Stephen D. Zucker(Brigham and Women's Hospital), Hugo E. Vargas(Mayo Clinic in Arizona), K. Rajender Reddy(Hospital of the University of Pennsylvania), Tarek Hassanein, Terry Box, Alex S. Befeler(Saint Louis University Hospital), Yuri Genyk, Khurram Jamil(Mallinckrodt (United States)), Michael P. Curry, Samuel H. Sigal(New York University), Kevin Korenblat(Washington University in St. Louis), Andrea Duchini, Rohit Satoskar, Jacqueline G. O’Leary(Veterans Health Administration), Michael K. Porayko, Joseph F. Buell, Florence Wong(University of Toronto), K. Gautham Reddy, Jasmohan S. Bajaj(Virginia Commonwealth University), Eyob Feyssa, Arun J. Sanyal(Virginia Commonwealth University), David S. Barnes, R. Todd Frederick(California Pacific Medical Center), S. Chris Pappas, Priya Grewal, Vishal Patel(King's College - North Carolina), Lorenzo Rossaro(University of California Davis Medical Center), Kris V. Kowdley(Liver Institute Northwest), Daniel Ganger(Northwestern University), Santiago J. Muñoz(Einstein Medical Center Philadelphia), Marie Noëlle Pépin, Nikroo Hashemi, Nathan J. Shores, Paul Angulo(University of Kentucky), Atif Zaman, David Kravetz, Víctor Araya, Ram Subramanian(Emory University), Sukru Emre(Ege University), Maria Hernandez, Marlyn J. Mayo(Southwestern Medical Center)
Cited by 305
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k